U.S. pharma giant copyright scrapped two experimental weight loss supplements last year—a once-every day tablet, lotiglipron, due to elevated liver enzymes in addition to a 2 times-day by day pill, danuglipron, because of sturdy Unintended effects—but CEO Albert Bourla has reported the company is determined to “Enjoy and win” while in the o